Medicine
IC-Green kit
IC-Green kit is a prescription medicine containing Indocyanine green, marketed by Renew Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68°F to 77°F).
Key facts
- Active ingredient (INN)
- Indocyanine green
- Brand
- IC-Green
- Dosage form
- Kit
- Packs
- 6 package
- Marketing authorisation holder
- Renew Pharmaceuticals
- Manufacturer
- Renew Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68°F to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- V04CX01 Indocyanine green
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 15 April 2025
- Identifiers
- DailyMed set ID ccd92843-1f0a-4ece-9978-4b300d158886NDC 70100-825, 70100-810Application NDA011525
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 6 package in 1 carton / 1 kit in 1 package * 1 injection, powder, lyophilized, for solution in 1 vial * 10 mL in 1 vial, plastic | 70100-810-02 | Renew Pharmaceuticals | 15 April 2026 |
| 6 package in 1 carton / 1 kit in 1 package * 1 injection, powder, lyophilized, for solution in 1 vial * 10 mL in 1 vial, plastic | 70100-825-02 | Renew Pharmaceuticals | 15 April 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 9 February 1959 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Indocyanine green
Clinical summary
Indocyanine green is a prescription medicine indicated for fluorescence imaging of vessels (micro- and macro- vasculature), blood flow and tissue perfusion before, during and after vascular, gastrointestinal, organ transplant, plastic, micro- and reconstructive surgeries. MedsAcross supplies Indocyanine green for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Indocyanine greenFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- IC-Green prescribing information (Renew Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need IC-Green kit for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.